Consensus conference:  Treatment of hypertriglyceridemia.
D001835:Body Weight; D002318:Cardiovascular Diseases / Q000209:etiology; D002994:Clofibrate / Q000627:therapeutic use; D015248:Gemfibrozil; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D006951:Hyperlipoproteinemias / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D010421:Pentanoic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood*; D014481:United States
D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D014280:Triglycerides; D002994:Clofibrate; D015248:Gemfibrozil